Connect Biopharma Holdings Limited

10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 8-K Regulation FD disclosure; Other events Apr 23, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Results of operations (earnings release) Mar 31, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events Mar 30, 2026 8-K Director or officer change Dec 23, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Regulation FD disclosure Sep 16, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Results of operations (earnings release) Aug 13, 2025 8-K Director or officer change Jul 22, 2025 8-K Terminated a material agreement Jul 21, 2025 8-K Other events Jul 17, 2025 8-K Regulation FD disclosure; Other events Jul 9, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release) May 15, 2025 8-K Regulation FD disclosure; Other events May 14, 2025 8-K Regulation FD disclosure; Other events May 13, 2025 8-K Regulation FD disclosure; Other events Apr 1, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Results of operations (earnings release) Mar 31, 2025 6-K Mar 28, 2025 6-K Dec 23, 2024 6-K Sep 6, 2024 6-K Sep 5, 2024 6-K Aug 2, 2024 6-K Jun 12, 2024 20-F Apr 16, 2024 6-K Apr 16, 2024 6-K Feb 12, 2024 6-K Dec 12, 2023 6-K Nov 21, 2023 6-K Nov 1, 2023 6-K Oct 20, 2023 6-K Sep 12, 2023 6-K Sep 12, 2023 6-K Jul 14, 2023 6-K Jun 23, 2023